The administration of fermented soymilk to a preclinical model of DSS-induced colitis showed that LAB enhanced the growth of SCFA-producing bacteria, with an increase in PPAR-γ and a subsequent reduction in the inflammatory cytokines [140]. The gene discussed is PPARG; the disease is colitis.